Who is prone to high levels of distress after prophylactic mastectomy and/or salpingo-ovariectomy?

Annals of Oncology

Volumn 18, Issue 10, 2007, Pages 1641-1645

  Bresser, P J C ^a   Van Gool, A R ^a   Seynaeve, C ^a   Duivenvoorden, H J ^a   Niermeijer, M F ^b   Van Geel, A N ^a   Menke, M ^a   Klijn, J G M ^a   Tibben, A ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BRCA1 2; Mastectomy; Prophylactic surgery; Psychology; Salpingo ovariectomy

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RISK; CLINICAL ASSESSMENT; COPING BEHAVIOR; DISTRESS SYNDROME; FAMILIAL CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MENTAL HEALTH; NEUROSIS; OVARIECTOMY; OVARY CANCER; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOSOCIAL CARE; SALPINGOOOPHORECTOMY; TREATMENT DURATION;

ADAPTATION, PSYCHOLOGICAL; ADULT; BREAST NEOPLASMS; FALLOPIAN TUBES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MASTECTOMY; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; OVARIECTOMY; PROSPECTIVE STUDIES; STRESS, PSYCHOLOGICAL;

EID: 34848919487     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm274     Document Type: Article

References (31)

1. Antoniou A, Pharoah PD, Narod S et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet 2003; 72: 1117-1130.
2. Ford D, Easton DF, Stratton M et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998; 62: 676-689.
3. Meijers-Heijboer H, van Geel B, van Putten WL et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. New Engl J Med 2001; 345: 159-164.
4. Verhoog LC, Brekelmans CT, Seynaeve C et al. Contralateral breast cancer risk is influenced by the age at onset in BRCA1 -associated breast cancer. Brit J Cancer 2000; 83: 384-386.
5. Grann VR, Jacobson JS, Sundararajan V et al. The quality of life associated with prophylactic treatments for women with BRCA1/2 mutations. Cancer J Sci Am 1999; 5: 283-292.
6. Hartmann LC, Schaid DJ, Woods JE et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. New Engl J Med 1999; 340: 77-84.
7. Hartmann LC, Sellers TA, Schaid DJ et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 2001; 93: 1633-1637.
8. Meijers-Heijboer E.J, Verhoog LC, Brekelmans CT et al. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 2000; 355: 2015-2020.
9. Schrag D, Kuntz KM, Garber JE et al. Decision analysis: Effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. New Engl J Med 1997; 336: 1465-1471.
10. Bleiker EM, Hahn DE, Aaronson NK. Psychosocial issues in cancer genetics: Current status and future directions. Acta Oncol 2003; 42: 276-286.
11. Dowdy SC, Stefanek M, Hartmann LC. Surgical risk reduction: Prophylactic salpingo-oophorectomy and prophylactic mastectomy. Am J Obstet Gynecol 2004; 191: 1113-1123.
12. Frost MH, Schaid DJ, Sellers TA et al. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. J Amer Med Ass 2000; 284: 319-324.
13. Hatcher MB, Fallowfield L, A'Hern R. The psychosocial impact of bilateral prophylactic mastectomy: Prospective study using questionnaires and semistructured interviews. Brit Med J 2001; 322: 76e.
14. Hopwood P, Keeling F, Long A et al. Psychological support needs for women at high genetic risk of breast cancer: Some preliminary indicators. Psychooncology 1998; 7: 402-412.
15. Lloyd S, Watson M, Waites B et al. Familial breast cancer: A controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counselling. Brit J Cancer 1996; 7A: 482-487.
16. Lodder LN, Frets PG, Trijsburg RW et al. One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: Emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat 2002; 73: 97-112.
17. Metcalfe KA, Esplen MJ, Goel V et al. Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy. Psychooncology 2004; 13: 14-25.
18. Bresser PJ, Seynaeve C, van Gool AR et al. Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women. Plast Reconstr Surg 2006; 117: 1675-1682.
19. van Oostrom I, Meijers-Heijboer H, Lodder LN et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: A 5-year follow-up study. J Clin Oncol 2003; 21: 3867-3874.
20. Bresser PJ, Seynaeve C, van Gool AR et al. The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy. Eur J Cancer 2007; 435: 95-103.
21. Wilde GJS, Amsterdamse Biografische Vragenlljst (ABV). Amsterdam: van Jossen 1963.
22. Te Nijenhuis J, Van der Flier H, Van Leeuwen L. The use of a test for neuroticism, extraversion, and rigidity for Dutch immigrant job-applicants. Appl Psychol 2003; 52: 630-647.
23. Schreurs PJG, Willige G van de, Tellegen B et al. Handleiding Utrechtse Coping Lijst: UCL. Lisse: Swets & Zeitlinger 1988.
24. Schreurs PJG, Willige G van de, Brosschot JF et al. De Utrechtse Copinglijst UCL (Dealing with Problems and Events). Lisse: Swets & Zeitlinger 1993.
25. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: A measure of subjective stress. Psychosom Med 1979; 41: 209-218.
26. Joseph S. Psychometric evaluation of Horowitz's Impact of Event Scale: A review. J Trauma Stress 2000; 13: 101-113.
27. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361-370.
28. Bjelland I, Dahl AA. Haug TT et al. The validity of the Hospital Anxiety and Depression Scale: An updated literature review. J Psychosom Res 2002; 52: 69-77.
29. Pieterse K, van Dooren S, Seynaeve C et al. Passive coping and psychological distress in women adhering to regular breast cancer surveillance. Psychooncology in press. 11 Jan 2007 DOI:10.1002/pon.1135.
30. Meiser B, Butow P, Friedlander M et al. Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer. J Clin Oncol 2000; 18: 2250-2257.
31. Julian-Reynier CM, Bouchard LJ, Evans DG et al. Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another. Cancer 2001; 92: 959-968.